These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17086052)

  • 1. AIDS vaccine development and challenge viruses: getting real.
    Vlasak J; Ruprecht RM
    AIDS; 2006 Nov; 20(17):2135-40. PubMed ID: 17086052
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
    Pope M; Haase AT
    Nat Med; 2003 Jul; 9(7):847-52. PubMed ID: 12835704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 5. Primate models of AIDS vaccine development.
    Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
    AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for live attenuated HIV.
    Desrosiers RC
    Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress towards a vaccine to prevent sexual transmission of HIV.
    Miller CJ; McGhee JR
    Nat Med; 1996 Jul; 2(7):751-2. PubMed ID: 8673919
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 11. Search for AIDS vaccine advances.
    Hum Vaccin Immunother; 2012 Feb; 8(2):151. PubMed ID: 22745942
    [No Abstract]   [Full Text] [Related]  

  • 12. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 13. A new era in HIV vaccine development.
    Lau CY; Velasco PP; Johnston MI
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):205-15. PubMed ID: 17402836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV vaccine development: the myth of Sisyphus modernized?
    Ljungberg K
    Expert Rev Vaccines; 2007 Dec; 6(6):879-82. PubMed ID: 18377348
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirus meeting. HIV/AIDS researchers reach for high-hanging fruit.
    Cohen J
    Science; 2009 Feb; 323(5917):996-7. PubMed ID: 19229005
    [No Abstract]   [Full Text] [Related]  

  • 20. Concerning the anti-major histocompatibility complex approach to HIV type 1 vaccine design.
    Luscher MA; Dela Cruz CS; MacDonald KS; Barber BH
    AIDS Res Hum Retroviruses; 1998 May; 14(7):541-4. PubMed ID: 9591707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.